Supply Chain Compliance Initiatives

Most companies see trade compliance as paperwork. But it's one of the few operational levers that can both reduce cost and protect brand reputation if done right. Here's how it's usually done wrong: – Inaccurate HS codes   – Unsupported use of Free Trade Agreements   – Mismatched documents across shipping paperwork   – Under- or over-declared transaction value   – Weak internal recordkeeping   – Relying on unqualified customs brokers or logistics partners Each of these creates delays, fines, and audit exposure. They don’t just erode margin. They erode trust—internally and externally. And they usually show up when your supply chain is already under stress. Here's what the top-performing companies do differently: – Run recurring classification and valuation audits   – Use systems to control document accuracy   – Train cross-functional teams on FTA qualifications   – Automate supplier and product screening   – Monitor global regulatory changes weekly   – Build compliance into sourcing contracts  They don’t wait for customs to come knocking. They treat compliance as a supply chain advantage. The result? Fewer delays, fewer penalties, smoother customs clearance—and higher margin reliability. Your supply chain doesn’t need another fire drill. It needs a compliance function that thinks like an operator. Start there 

⚠️ Exporting to the US? The Uyghur Forced Labor Prevention Act (UFLPA) could stop your goods at the border. The law mandates that importers prove—clearly and convincingly—that no part of their supply chain involves forced labor, especially linked to Xinjiang. For Asia-based manufacturers, that means demonstrating traceability all the way down to raw materials. 📦 This is happening at a time when trade routes are shifting, tariff rules are tightening, and supply chains are already under pressure. UFLPA adds another layer of operational complexity—especially for suppliers selling into US markets. Here are six tech-enabled practices that can support compliance: 🌐 End-to-end supply chain mapping – with SCRM software and multi-tier tools for visibility 🧾 Automated supplier screening – using compliance platforms and denied party lists 📑 Digital tracing & documentation – centralized records to support CBP response 📡 Real-time monitoring & analytics – powered by AI to detect and flag risks early 🛠️ Due diligence & remediation integration – verifiable action through third-party platforms 🔄 Regular updates & adaptability – via cloud-based tools aligned with evolving regulations It's also important to note that technology simplifies the process (and these processes are only going to get more complex)—but it’s only as strong as the due diligence program behind it. #UFLPA #AsiaExports #CBPCompliance #TradeComplexity #ForcedLabor #SupplyChainRisk #AICompliance #DigitalDueDiligence #EthicalSourcing

What the German Supply Chain Act is quietly changing inside companies Over the past year, I’ve spoken with several companies preparing for or responding to scrutiny under the German Supply Chain Act (LkSG). What strikes me most is this: The law is not primarily testing whether you have policies. It is testing whether your systems actually help you understand and manage risk. Under the LkSG, companies are expected to implement risk management, conduct risk analyses, establish complaints mechanisms, and take preventive and remedial measures. But the obligation is not to guarantee a violation-free supply chain. It is to demonstrate that you have taken appropriate and effective steps based on risk. This distinction matters. Because it shifts the focus away from symbolic compliance. And toward operational intelligence. I saw very clearly why this matters during Covid. When lockdowns started, some companies suddenly discovered that critical components or materials came from regions that were completely shut down. Production stopped. Orders could not be fulfilled. Revenue was directly impacted. What stood out was not the disruption itself. It was the lack of visibility. If a robust due diligence system had already been in place. With clear mapping, risk prioritisation, and supplier insight. These dependencies would have been known beforehand. Due diligence would not have prevented Covid. But it would have prevented the surprise. And surprise is what makes disruption expensive. What does not hold up well: • Blanket questionnaires without prioritisation • Supplier declarations without deeper insight • Treating due diligence as a reporting exercise • Delegating responsibility fully to audits or Tier 1 What does hold up well: • Knowing where your highest risks actually are. Including deeper in the supply chain • Prioritising based on severity and likelihood • Having complaints mechanisms that people trust and use • Being able to show how insights lead to concrete action and decisions Companies that treat due diligence as a strategic function gain something far more valuable than legal protection. They gain visibility. Visibility into supplier reliability. Visibility into operational vulnerabilities. Visibility into where disruption, cost, or reputational damage may emerge next. Compliance is the trigger. Operational resilience is the outcome. I’m curious to hear from practitioners and legal experts here: What do you focus on when assessing whether due diligence is credible and sufficient? What gives you confidence that a system works in practice? And equally important. What signals to you that it is only compliance on paper? Would value hearing what you are seeing in practice. #LkSG #duediligence

3 AI Moves to Transform Trade Compliance in 2025 Half of trade compliance work is tied up in typing, validating, or rekeying data, rather than higher-value work like tariff strategy, risk analysis, or auditing. Trade compliance is one of the most data-heavy functions in Supply Chain. If I were running compliance right now, I’d make three moves today: → Automate Data Entry AI can extract HTS codes, declared values, country of origin, and duties directly from invoices, bills of lading, and packing lists. Filings upload in minutes, errors drop, and teams focus on exceptions. → Real-Time Tariff Monitoring Compliance teams must track dozens of official sources including: - Federal Register for new rules, executive orders, and statutory changes - CBP Cargo Systems Messaging Service (CSMS) for operational alerts and bulletins - Executive Orders issued directly from the White House - USTR notifications covering negotiated trade actions and retaliatory measures AI can monitor these sources in real time, flagging new tariff actions the moment they’re published. → AI Compliance Assistant Turn SOPs, customs rulings, and country guides into a searchable AI assistant. Frontline teams could ask: “What’s the filing requirement for footwear from Vietnam?” and get an answer in seconds. Trade has never moved this fast. AI won’t replace expertise...it multiplies it, giving compliance teams the leverage to keep pace and focus on higher-value decisions. → If you had to start with just one...data entry automation, tariff monitoring, or an AI assistant...where would you place your bet? #TradeCompliance #SupplyChain #AI #Tariffs

Compliance risk has shifted. It is no longer a brand problem. It is a capacity crisis. The situation: Regulatory acceleration By 2026, frameworks such as the EU Digital Product Passport (DPP) and CSDDD will require brands to provide sustainability data at a depth and frequency not previously expected—lot-level traceability, chemical inputs, water use, and continuous digital evidence. Compliance is moving from a periodic, pass/fail audit to an always-on data requirement. The complication: a data maturity gap There is a structural imbalance across the value chain. While brands have largely digitized front-end systems (e-commerce, CRM, reporting), much of the upstream supply chain remains analog. Industry assessments indicate that a majority of Tier-2 suppliers still rely on manual tools spreadsheets or paper for compliance-related data. The bottleneck The constraint is not willingness or intent. It is capacity. Suppliers often meet standards in practice but lack the digital infrastructure to evidence compliance at the speed and granularity regulators now expect. The consequence: a compliance liquidity crunch As requirements scale, the pool of audit- and DPP-ready suppliers is shrinking relative to demand. This creates a new risk: brands competing for limited compliant capacity, not due to production constraints—but due to data readiness. The resolution: from policing to capacity building Treating data gaps as “non-compliance” misses the point. They are operational risks. The brands that navigate 2026 successfully will not be those with the strictest codes of conduct, but those that invest in Supplier Data Capacity—digitizing data capture, validation, and continuity at the source. Question for procurement leaders: Are you forecasting data capacity alongside production capacity for Q3/Q4? #SupplyChainStrategy #TextileCompliance #Procurement #Sustainability #DPP

One missed compliance check can stop your product from reaching patients. In the pharmaceutical industry, this isn’t just an operational inconvenience-it’s a matter of trust, safety, and lives. Yet, trade compliance is often treated as an afterthought, only becoming a priority when something goes wrong. Here’s what’s at stake: 🔹 Operational Risks Delays at customs can disrupt clinical trials, product launches, and patient assistance programs. A single misstep-like incomplete documentation or selling to a restricted entity-can mean hefty fines or even losing export privileges. 🔹 Reputational Risks A compliance issue doesn’t just stay in the boardroom. It hits the headlines. Trust erodes, healthcare professionals hesitate, and patients lose faith in your brand. The reality is clear: pharmaceutical companies must embed trade compliance into their supply chain processes. It’s not optional-it’s essential. How can you make this happen? → Secure management support to foster a culture of compliance. → Conduct risk assessments to identify vulnerabilities in your export activities. → Develop internal controls with clear procedures for valuation, classification, and partner screening. → Schedule regular audits to catch issues early. → Provide ongoing training so your teams understand what’s required. → Maintain accurate records to demonstrate your compliance efforts. Compliance isn’t just about avoiding penalties. It’s about ensuring that life-saving products reach patients without unnecessary delays. When it’s done right, it enables efficiency, protects your reputation, and strengthens your supply chain. What steps has your organization taken to integrate compliance into your processes? I am Elizabeth Lomax, import/export compliance expert helping pharma and biotech companies create more efficient international supply chains. DM me or visit my LinkedIn profile to learn more. To stay updated, click the notification bell on my profile. 🔔

The Drug Supply Chain Security Act (DSCSA) is not just a regulatory requirement; it is a critical framework that delineates lawful operations from criminal exposure. The recent Safe Chain Solutions case underscores the severe consequences of non-compliance, which can result in felony charges for executives. To ensure compliance and mitigate risks, organizations must focus on the following key areas: Authorized Trading Partners Only: Verify and document that every manufacturer, distributor, and dispenser you transact with is DSCSA-authorized. Establish a routine audit process to confirm partner credentials and licensing. Transaction Documentation & Record Integrity: Ensure accurate DSCSA transaction records (T3s) are exchanged and retained for a minimum of six years. Implement electronic reconciliation systems to detect gaps or inconsistencies between product identifiers and records. Suspect Product Response Protocols: Establish clear procedures for quarantining, investigating, and documenting suspect or illegitimate products—train staff to promptly escalate red flags and notify the FDA and trading partners within the required timeframes. Robust DSCSA compliance not only safeguards patients but also stabilizes operations and protects leadership from liability. Compliance is a strategic risk management tool that cannot be overlooked. https://lnkd.in/e_p-bCYQ